E. Tekgündüz Et Al. , "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?," Transfusion and Apheresis Science , vol.54, no.1, pp.30-34, 2016
Tekgündüz, E. Et Al. 2016. Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. Transfusion and Apheresis Science , vol.54, no.1 , 30-34.
Tekgündüz, E., Kaya, A. H., Bozdağ, S. C., Koçubaba, Ş., Kayikçi, Ö., Namdaroğlu, S., ... Uğur, B.(2016). Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. Transfusion and Apheresis Science , vol.54, no.1, 30-34.
Tekgündüz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?," Transfusion and Apheresis Science , vol.54, no.1, 30-34, 2016
Tekgündüz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." Transfusion and Apheresis Science , vol.54, no.1, pp.30-34, 2016
Tekgündüz, E. Et Al. (2016) . "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." Transfusion and Apheresis Science , vol.54, no.1, pp.30-34.
@article{article, author={Emre Tekgündüz Et Al. }, title={Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?}, journal={Transfusion and Apheresis Science}, year=2016, pages={30-34} }